The trademark application Boostrix was filed by GlaxoSmithKline Biologicals S.A., a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on April 22, 2002, and it was registered by office on November 26, 2002 without any oppositions.
The application was filed in English (French was selected as the second language).
Two renewals of the trademark were recorded, one on August 17, 2011, and the other one on April 15, 2021.
Change of name and address of the trademark registration was recorded on June 18, 2007. Change of name and professional address of the trademark registration was recorded on July 2, 2007. Appointment and Replacement of representative of the trademark registration was recorded on September 11, 2007. Appointment and Replacement of representative of the trademark registration was recorded on September 24, 2007. Appointment and Replacement of representative of the trademark registration was recorded on September 24, 2007. Relative errors of the trademark registration was recorded on February 21, 2012. Appointment and Replacement of representative of the trademark registration was recorded on May 27, 2016. Deletion of the representative of the trademark registration was recorded on January 7, 2021. Appointment and Replacement of representative of the trademark registration was recorded on February 23, 2021.